DIURNAL CHANGE IN QT INTERVALS IN DILATED CARDIOMYOPATHY AND HYPERTROPHIC CARDIOMYOPATHY

被引:14
|
作者
YANAGISAWAMIWA, A
INOUE, H
SUGIMOTO, T
机构
[1] Second Department of Internal Medicine, Tokyo University Hospital, Bunkyo-ku, Tokyo, 113
来源
AMERICAN JOURNAL OF CARDIOLOGY | 1991年 / 67卷 / 16期
关键词
D O I
10.1016/0002-9149(91)90476-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In patients with cardiomyopathy, cardiovascular responses to catecholamines and related substances are known to differ from those in normal subjects. 1-4 In the case of hypertrophic cardiomyopathy (HC), the presence of hyperreactivity of the adrenergic system is suggested by several clinical features.5 The increase in left ventricular contractility induced by isoproterenol or epinephrine is greater in patients with HC than in normal subjects.1,2 In dilated cardiomyopathy (DC) or failing hearts, systemic levels of norepinephrine are often elevated markedly, indicating generalized sympathetic activation to compensate for congestive heart failure.6 The positive inotropic effect of β-adrenergic receptor agonists is, however, known to be attenuated in patients with DC.3,4 In the present study, we determined cardiac responses to change in autonomic nervous tone in patients with HC and in those with DC by using 2 indirect measures of autonomic nervous function: diurnal change in QT intervals7,8 and variation in RR intervals.9,10. © 1991.
引用
收藏
页码:1428 / 1430
页数:3
相关论文
共 50 条
  • [31] Dilated cardiomyopathy masquerading as long QT syndrome
    Walls, J
    Dipchand, A
    Sanatani, S
    [J]. PEDIATRIC CARDIOLOGY, 2006, 27 (01) : 156 - 159
  • [32] Hypertrophic cardiomyopathy: two homozygous cases with "typical" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy
    Nanni, L
    Pieroni, M
    Chimenti, C
    Simionati, B
    Zimbello, R
    Maseri, A
    Frustaci, A
    Lanfranchi, G
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 309 (02) : 391 - 398
  • [33] Dilated Cardiomyopathy Masquerading as Long QT Syndrome
    J. Walls
    A. Dipchand
    S. Sanatani
    [J]. Pediatric Cardiology, 2006, 27 : 156 - 159
  • [34] Hypertrophic cardiomyopathy: two homozygous cases with "typical hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy
    Nanni, L
    Chimenti, C
    Pieroni, M
    Simionati, B
    Zimbello, R
    Lanfranchi, G
    Maseri, A
    Frustaci, A
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 : 555 - 555
  • [35] Primary prophylaxis of sudden death in hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and dilated cardiomyopathy
    Klein, GJ
    Krahn, AD
    Skanes, AC
    Yee, R
    Gula, LJ
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2005, 16 (09) : S28 - S34
  • [36] Common pathways for primary hypertrophic and dilated cardiomyopathy
    Kroumpouzou, E
    Gomatos, IP
    Kataki, A
    Karayannis, M
    Dangas, GD
    Toutouzas, P
    [J]. HYBRIDOMA AND HYBRIDOMICS, 2003, 22 (01): : 41 - 45
  • [37] Sympathetic overactivation in dilated phase of hypertrophic cardiomyopathy
    Ushijima, R.
    Joho, S.
    Oda, Y.
    Harada, D.
    Hirai, T.
    Asanoi, H.
    Inoue, H.
    [J]. EUROPEAN HEART JOURNAL, 2011, 32 : 914 - 914
  • [38] Stress-echocardiography in hypertrophic and dilated cardiomyopathy
    Duplyakov, D. V.
    [J]. KARDIOLOGIYA, 2007, 47 (07) : 68 - 71
  • [39] Clinical and genetic aspects of hypertrophic and dilated cardiomyopathy
    Meder, B.
    Katus, H. A.
    [J]. INTERNIST, 2012, 53 (04): : 408 - +
  • [40] Reversible transition from a hypertrophic to a dilated cardiomyopathy
    Spillmann, Frank
    Kuehl, Uwe
    Van Linthout, Sophie
    Dominguez, Fernando
    Escher, Felicitas
    Schultheiss, Heinz-Peter
    Pieske, Burkert
    Tschoepe, Carsten
    [J]. ESC HEART FAILURE, 2016, 3 (02): : 138 - 142